Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 3, Pages 1713-1724Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c02077
Keywords
-
Categories
Ask authors/readers for more resources
SLC-149 is a more effective inhibitor of CAIX activity than acetazolamide, thermally stabilizing CAIX-mimic at lower concentrations compared to CAII. It shows little effect on cytotoxicity but inhibits cell growth and migration effectively.
Carbonic anhydrase IX (CAIX) is considered a target for therapeutic intervention in solid tumors. In this study, the efficacy of the inhibitor, 4-(3-(2,4-difluorophenyl)-oxoimidazolidin-1-yl)benzenesulfonamide (SLC-149), is evaluated on CAIX and a CAIX-mimic. We show that SLC-149 is a better inhibitor than acetazolamide against CAIX. Binding of SLC-149 thermally stabilizes CAIX-mimic at lower concentrations compared to that of CAII. Structural examinations of SLC-149 bound to CAIX-mimic and CAII explain binding preferences. In cell culture, SLC-149 is a more effective inhibitor of CAIX activity in a triple-negative breast cancer cell line than previously studied sulfonamide inhibitors. SLC-149 is also a better inhibitor of activity in cells expressing CAIX versus CAXII. However, SLC-149 has little effect on cytotoxicity, and high concentrations are required to inhibit cell growth, migration, and invasion. These data support the hypothesis that CAIX activity, shown to be important in regulating extracellular pH, does not underlie its ability to control cell growth.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available